FLIP GENE THERAPEUTICS Trademark

Trademark Overview


On Friday, February 18, 2022, a trademark application was filed for FLIP GENE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FLIP GENE THERAPEUTICS trademark a serial number of 97274418. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, August 18, 2023. This trademark is owned by Flip Gene Therapeutics Inc.. The FLIP GENE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biologic preparations for use in immunology, oncology, and pain management; Biological components being a component in immunosuppressants and therapeutic preparations for use in oncology and pain management and genetic diseases; Biological compound for medical use, namely, protein and RNA gene switches; Therapeutic agents for allowing dynamic control of gene expression in gene therapy and cell therapy

Medical scientific testing, research and development services in the fields of pharmaceuticals, biologics, gene therapies, and gene expression regulation; Drug discovery services; Providing medical scientific information in the fields of diseases and disorders involving the immune system, pharmaceuticals, and biologics
flip gene therapeutics

General Information


Serial Number97274418
Word MarkFLIP GENE THERAPEUTICS
Filing DateFriday, February 18, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, August 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biologic preparations for use in immunology, oncology, and pain management; Biological components being a component in immunosuppressants and therapeutic preparations for use in oncology and pain management and genetic diseases; Biological compound for medical use, namely, protein and RNA gene switches; Therapeutic agents for allowing dynamic control of gene expression in gene therapy and cell therapy
Disclaimer with Predetermined Text"GENE THERAPEUTICS"
Goods and ServicesMedical scientific testing, research and development services in the fields of pharmaceuticals, biologics, gene therapies, and gene expression regulation; Drug discovery services; Providing medical scientific information in the fields of diseases and disorders involving the immune system, pharmaceuticals, and biologics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFlip Gene Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Friday, August 18, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, August 18, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, August 18, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, April 30, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sunday, April 30, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, February 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Friday, January 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 3, 2022NON-FINAL ACTION E-MAILED
Saturday, December 3, 2022NON-FINAL ACTION WRITTEN
Friday, December 2, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 22, 2022NEW APPLICATION ENTERED